Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Resch

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Plos Medicine|July 27, 2006
Prospects for advancing tuberculosis control efforts through novel therapiesJoshua A Salomon, James O Lloyd-Smith, Wayne M Getz, et al.
The Journal of Craniofacial Surgery|June 17, 2015
Measuring and Comparing the Cost-Effectiveness of Surgical Care Delivery in Low-Resource Settings: Cleft Lip and Palate as a ModelBerit Hackenberg, Margarita S Ramos, Alexander Campbell, et al.
Health Affairs (Project Hope)|September 8, 2010
Adopting a surgical safety checklist could save money and improve the quality of care in U.S. hospitalsMarcus E Semel, Stephen Resch, Alex B Haynes, et al.
BMC Medicine|March 8, 2022
WHO-led consensus statement on vaccine delivery costing: process, methods, and findingsAnn Levin, Laura Boonstoppel, Logan Brenzel, et al.
Vaccine|April 29, 2015
ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisionsBarbara Jauregui, Cara Bess Janusz, Andrew D Clark, et al.
Vaccine|April 29, 2015
Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in BrazilHillegonda Maria Dutilh Novaes, Patrícia Coelho de Soárez, Gulnar Azevedo Silva, et al.
Health Policy and Planning|March 13, 2018
The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-upRobert Hecht, Lindsey Hiebert, Wendy C Spearman, et al.
Lancet (London, England)|July 6, 2025
The case for optimal investment in combating HIV, tuberculosis, and malaria: a global modelling studyTimothy B Hallett, Nicolas A Menzies, Stephen Resch, et al.
AIDS (London, England)|September 15, 2017
The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitationsEmily P Hyle, Ilesh V Jani, Katherine L Rosettie, et al.
Lancet (London, England)|June 29, 2015
Defeating AIDS--advancing global healthPeter Piot, Salim S Abdool Karim, Robert Hecht, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Plos Medicine|July 27, 2006
Prospects for advancing tuberculosis control efforts through novel therapiesJoshua A Salomon, James O Lloyd-Smith, Wayne M Getz, et al.
The Journal of Craniofacial Surgery|June 17, 2015
Measuring and Comparing the Cost-Effectiveness of Surgical Care Delivery in Low-Resource Settings: Cleft Lip and Palate as a ModelBerit Hackenberg, Margarita S Ramos, Alexander Campbell, et al.
Health Affairs (Project Hope)|September 8, 2010
Adopting a surgical safety checklist could save money and improve the quality of care in U.S. hospitalsMarcus E Semel, Stephen Resch, Alex B Haynes, et al.
BMC Medicine|March 8, 2022
WHO-led consensus statement on vaccine delivery costing: process, methods, and findingsAnn Levin, Laura Boonstoppel, Logan Brenzel, et al.
Vaccine|April 29, 2015
ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisionsBarbara Jauregui, Cara Bess Janusz, Andrew D Clark, et al.
Vaccine|April 29, 2015
Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in BrazilHillegonda Maria Dutilh Novaes, Patrícia Coelho de Soárez, Gulnar Azevedo Silva, et al.
Health Policy and Planning|March 13, 2018
The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-upRobert Hecht, Lindsey Hiebert, Wendy C Spearman, et al.
Lancet (London, England)|July 6, 2025
The case for optimal investment in combating HIV, tuberculosis, and malaria: a global modelling studyTimothy B Hallett, Nicolas A Menzies, Stephen Resch, et al.
AIDS (London, England)|September 15, 2017
The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitationsEmily P Hyle, Ilesh V Jani, Katherine L Rosettie, et al.
Lancet (London, England)|June 29, 2015
Defeating AIDS--advancing global healthPeter Piot, Salim S Abdool Karim, Robert Hecht, et al.
Pageof 5